Company intelligence / Profile preview

Swiss BioQuant

Reinach, Basel-Landschaft (BL), Switzerlandswissbioquant.com ↗

Ownership: Private
Employees: ~40
Development stage: Other

Overview

Swiss BioQuant is a GLP-certified bioanalytical contract research organization with over 20 years of experience. It specializes in LC-MS/MS and ligand-binding assays for both small molecules and biologics, supporting pharmaceutical and biotechnology companies with method development, validation, sample analysis, biomarker development/validation, pharmacokinetic studies, liposome drug analysis, and more. The company operates in a 21 CFR part 11 compliant environment with high standards of quality assurance.

Modalities: Small moleculeBiologicLarge molecule
Industry: Contract Research Organization

Partnerships

Collaborates broadly with pharmaceutical companies, biotechs, and research institutions to support drug discovery/development programs

Beyond the preview

Go deeper on Swiss BioQuant.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Swiss BioQuant.

Explore the full profile